StockGlow

UCB SA (UNC.F)

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

224.30-0.10%Healthcare
Compare UNC.F with
StockGlow Score
23
Leaning Bearish
BearishBullish
1 year ago+18.6%

The outlook

UCB SA currently reads as leaning bearish based on below its 50- & 200-day averages, 41% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range41% of the way from its 52-week low to high
Market cap
$42.70B
52-wk high
285.40
52-wk low
181.80
50-day avg
250.46
200-day avg
248.25
Trailing P/E
28.0

Similar stocks

TE1.FBio-Techne Corporation$62.52+0.58%CSJ.FCSL Limited$76.51-4.34%DUL.FAlnylam Pharmaceuticals, Inc.$178.20-28.66%RPD.MURoyalty Pharma plc$51.83+0.00%UNC0.FUCB SA$116.00-6.45%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy